This is the authors' abstract. We don't add key points for this paper.
In this 16-week trial involving children with type 1 diabetes, the glucose level was in the target range for a greater percentage of time with the use of a closed-loop system than with the use of a sensor-augmented insulin pump. (Funded by Tandem Diabetes Care and the National Institute of Diabetes and Digestive and Kidney Diseases; ClinicalTrials.gov number, NCT03844789.).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Breton et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: